Mirum Pharmaceuticals (MIRM) Long-Term Investments (2019 - 2026)

Mirum Pharmaceuticals has reported Long-Term Investments for 6 years, with the latest figure at $34.4 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments rose 64.27% year-over-year to $34.4 million; the trailing twelve-month figure through Mar 2026 stood at $34.4 million (up 64.27% YoY), and the FY2025 full-year result was $8.1 million, down 35.29% from the prior year.
• Long-Term Investments for Q1 2026 stood at $34.4 million, up from $8.1 million in the prior quarter.
• The five-year high for Long-Term Investments was $34.4 million in Q1 2026, with the low at $2.5 million in Q3 2025.
• Average Long-Term Investments over 3 years is $15.2 million, with a median of $14.8 million recorded in 2024.
• Year-over-year, Long-Term Investments plunged 73.5% in 2025 and jumped 64.27% in 2026.
• Tracing MIRM's Long-Term Investments over 3 years: stood at $12.5 million in 2024, then plunged by 35.29% to $8.1 million in 2025, then soared by 323.85% to $34.4 million in 2026.
• The last three Long-Term Investments figures came in at $34.4 million (Q1 2026), $8.1 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.

Peer Comparison